The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial AE Metropulos, HG Munshi, DR Principe eBioMedicine 86, 104380, 2022 | 24 | 2022 |
Inhibiting MNKs promote macrophage immunosuppressive phenotype to limit CD8+ T cell antitumor immunity TND Pham, C Spaulding, MA Shields, AE Metropulos, DN Shah, ... JCI insight 7 (9), 2022 | 6 | 2022 |
Intestinal adenocarcinoma originating from an undiagnosed Meckel’s diverticulum DR Principe, P Nesper, AE Metropulos, J Rubin, MN Marinov Journal of Surgical Case Reports 2022 (5), rjac128, 2022 | 4 | 2022 |
Chromium (VI) promotes lung cancer initiation by activating EGF/ALDH1A1 signalling AE Metropulos, JH Becker, DR Principe Clinical and Translational Discovery 2 (4), e155, 2022 | 1 | 2022 |
Abstract LB232: Targeting MEK activity in pancreatic tumors resistant to the combination of 5FU, irinotecan, and oxaliplatin promotes response to immunotherapy TD Pham, AE Metropulos, N Mubin, DN Shah, C Spaulding, M Shields, ... Cancer Research 83 (8_Supplement), LB232-LB232, 2023 | | 2023 |
Deletion of G alpha 13 promotes inflammation in the KPC mouse model of pancreatic cancer. MA Shields, AE Metropulos, C Spaulding, TND Pham, HG Munshi CANCER RESEARCH 82 (22), 139-140, 2022 | | 2022 |
Abstract C042: Deletion of Gα13 promotes inflammation in the KPC mouse model of pancreatic cancer MA Shields, AE Metropulos, C Spaulding, TND Pham, HG Munshi Cancer Research 82 (22_Supplement), C042-C042, 2022 | | 2022 |
Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin MA Shields, C Spaulding, AE Metropulos, MG Khalafalla, TND Pham, ... Cell Reports 38 (9), 110441, 2022 | | 2022 |